Background: Allogeneic hematopoietic stem cell transplantation (Allo-HSCT) is considered a potential therapy for long-term survival, used as post-remission therapy in leukemias whose response to earlier treatments was not effective. Relapse and associated disease progression are some of the main complications after the transplantation period that may lead to uncertain clinical endings. Transplantation monitorin...
Prémio atribuído pelo International Research Promotion Council a Amílcar C. Falcão: Eminent Scientist of the Year 2006. Europe; Abstract Objective The aim of the present study was to investigate the usefulness of the CA-125 area under the curve (AUC) as a new kinetic parameter for predicting overall survival in patients with ovarian cancer. In addition, the relationship of CA-125 AUC with other prognostic facto...